ArticleFrontiers in pharmacology2024

Schisandrin C enhances type I IFN response activation to reduce tumor growth and sensitize chemotherapy through antitumor immunity.

Huijie Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.